Herein, we searched the database to retrieve the putative targets of metformin in the treatment of DKD, involved in aging and DNA damage; the core targets include ATM, CHK2, P21, CDKN1B, MDM2, and TP53. This evidence concerns the gene CDKN1B and diabetic kidney disease.